Skip to main content

Table 1 Identification of the 25 Leishmania isolates used in this study from 8 Leishmania/HIV coinfected patients obtained during VL clinical episodes or non-clinical episodes, from bone marrow or peripheral blood mononuclear cell samples; and their genotyping and clustering analysis results

From: Multilocus microsatellite typing of Leishmania infantum isolates in monitored Leishmania/HIV coinfected patients

Patient code

Patient isolates

Sex

Age

Risk factor

Time from first episode (in months)

Clinical status

Sample Type

WHO Code

Genotype (G)

Cluster (C)

P1

1a

Man

30

IVDU

June

CE

PBMC

MHOM/ES/00/BCN-278

G14

C2b

1b

   

8 m

CE

PBMC

MHOM/ES/01/BCN-376

G13

C2b

1c

   

20 m

CE

PBMC

MHOM/ES/02/BCN-464

G15

C2b

P2

2a

Man

44

IVDU

July

CE

BM

MHOM/ES/00/BCN-284

G3

C1

2b

   

2 m

CE

BM

MHOM/ES/00/BCN-289

G2

C1

P3

3a

Man

36

nd

May

CE

BM

MHOM/ES/01/BCN-404

G16

C2

3b

   

7 m

NE

PBMC

MHOM/ES/01/BCN-455

G16

C2

3c

   

12 m

CE

BM

MHOM/ES/02/BCN-492

G16

C2

P4

4a

Man

34

IVDU

April

CE

BM

MHOM/ES/02/BCN-475

G9

C2

4b

   

6 m

CE

BM

MHOM/ES/02/BCN-508

G9

C2

P5

5a

Man

36

IVDU

September

CE

BM

MHOM/ES/94/BCN-123

G10

C2

5b

   

5 m

CE

BM

MHOM/ES/95/BCN-130

G1

-

P6

6a

Man

33

IVDU

October

CE

BM

MHOM/ES/00/BCN-298

G11

C2

6b

   

6 m

CE

BM

MHOM/ES/01/BCN-400

G5

C2

6c

   

17 m

CE

BM

MHOM/ES/02/BCN-470

G12

C2

P7

7a

Man

41

nd

October

CE

PBMC

MHOM/ES/01/BCN-430

G7

C2a

7b

   

3 m

NE

BM

MHOM/ES/02/BCN-460

G7

C2a

7c

   

4 m

CE

PBMC

MHOM/ES/02/BCN-472

G6

C2a

P8

8a

Woman

27

IVDU

October

CE

PBMC

MHOM/ES/00/BCN-293

G4

C2

8b

   

1 m

NE

PBMC

MHOM/ES/00/BCN-306

G7

C2a

8c

   

1 m + 6 days

NE

PBMC

MHOM/ES/01/BCN-307

G8

C2

8d

   

3 m

NE

PBMC

MHOM/ES/01/BCN-369

G16

C2

8e

   

7 m

CE

PBMC

MHOM/ES/01/BCN-405

G18

C2

8f

   

9 m

NE

PBMC

MHOM/ES/01/BCN-422

G17

C2

8 g

   

29 m

NE

PBMC

MHOM/ES/03/BCN-561

G16

C2

  1. IVDU intravenous drug user, nd not determined, CE clinical episode, NE non-clinical episode, PBMC peripheral blood mononuclear cell, BM bone marrow